TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Prices $16.6 Million Registered Direct Offering
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in gross proceeds. The offering consists of 2,625,362 shares of common stock and pre-funded warrants priced at $6.31 per share, with the transaction priced at the market under Nasdaq rules. The company said the financing materially strengthens its balance sheet and provides additional flexibility to pursue strategic priorities. LIXTE expects the offering to close on or about June 3, 2026, subject to customary closing conditions, and plans to use the net proceeds for general corporate purposes, working capital…

